Table 3 IRs of hospitalisation for VTEa per 1000 person-years in the cancer cohort (n=40 994) and aRRsb of hospitalisation for venous thromboembolism in the cancer cohort compared with the general-population (n=204 970) (DCR, 1997–2003)c
Characteristic | N | IR (95% CI) | aRR b (95% CI) |
---|---|---|---|
Cancer stage c | |||
Stage I | 1240 | 44 (2.7–7.1) | 2.9 (1.5–5.5) |
Stage II | 14520 | 44.9 (4.0–5.7) | 2.9 (2.4–3.5) |
Stage III | 10499 | 11.1 (9.7–12.7) | 7.5 (6.0–9.4) |
Stage IV | 9125 | 27.7 (243.0–32.0) | 17.1 (12.6–23.3) |
Unspecified | 5610 | 12.2 (10.1–14.8) | 5.6 (4.1–7.5) |
Treatment c,d | |||
No/symptomatic | 8565 | 20.8 (17.3–25.0) | 8.4 (6.2–11.4) |
Chemotherapy only | 3026 | 23.1 (19.0–28.1) | 18.5 (11.9–28.7) |
Radiation only | 2512 | 10.1 (7.2–14.1) | 8.9 (5.0–16.0) |
Surgery only | 16564 | 6.5 (5.7–7.3) | 3.2 (2.7- 3.8) |
Othere | 781 | 13.4 (7.6–23.7) | 6.0 (2.3–15.6) |
Combination therapy | 8625 | 8.5 (7.3–9.9) | 8.6 (6.7–11.1) |
Unspecified | 921 | 9.2 (4.8–17.6) | 5.8 (2.1–16.6) |
Treatment including c | |||
No/symptomatic | 8565 | 20.8 (17.3–25.0) | 8.4 (6.2–11.4) |
Chemotherapy | 7154 | 14.0 (12.2–16.2) | 16.2 (12.0–21.7) |
Radiation | 6943 | 8.2 (6.8–9.9) | 7.9 (5.8–10.7) |
Surgery | 24525 | 7.0 (6.3–7.7) | 4.1 (3.6- 4.7) |
Othere | 781 | 13.4 (7.6–23.7) | 6.0 (2.3–15.6) |
Unspecified | 921 | 9.2 (4.8–17.6) | 5.8 (2.1–16.6) |